Skip to main content Accessibility help

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

  • R. Uher (a1), R. H. Perlis (a2), N. Henigsberg (a3), A. Zobel (a4), M. Rietschel (a5), O. Mors (a6), J. Hauser (a7), M. Z. Dernovsek (a8), D. Souery (a9), M. Bajs (a3), W. Maier (a4), K. J. Aitchison (a1), A. Farmer (a1) and P. McGuffin (a1)...



Symptom dimensions have not yet been comprehensively tested as predictors of the substantial heterogeneity in outcomes of antidepressant treatment in major depressive disorder.


We tested nine symptom dimensions derived from a previously published factor analysis of depression rating scales as predictors of outcome in 811 adults with moderate to severe depression treated with flexibly dosed escitalopram or nortriptyline in Genome-based Therapeutic Drugs for Depression (GENDEP). The effects of symptom dimensions were tested in mixed-effect regression models that controlled for overall initial depression severity, age, sex and recruitment centre. Significant results were tested for replicability in 3637 adult out-patients with non-psychotic major depression treated with citalopram in level I of Sequenced Treatment Alternatives to Relieve Depression (STAR*D).


The interest-activity symptom dimension (reflecting low interest, reduced activity, indecisiveness and lack of enjoyment) at baseline strongly predicted poor treatment outcome in GENDEP, irrespective of overall depression severity, antidepressant type and outcome measure used. The prediction of poor treatment outcome by the interest-activity dimension was robustly replicated in STAR*D, independent of a comprehensive list of baseline covariates.


Loss of interest, diminished activity and inability to make decisions predict poor outcome of antidepressant treatment even after adjustment for overall depression severity and other clinical covariates. The prominence of such symptoms may require additional treatment strategies and should be accounted for in future investigations of antidepressant response.


Corresponding author

*Address for correspondence: Dr R. Uher, P080, SGDP, Institute of Psychiatry, 16 De Crespigny Park, London SE5 8AF, UK. (Email:


Hide All
Beck, AT, Ward, CH, Mandelson, M, Mock, J, Erbaugh, J (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 561571.
Bjelland, I, Lie, SA, Dahl, AA, Mykletun, A, Stordal, E, Kraemer, HC (2009). A dimensional versus a categorical approach to diagnosis: anxiety and depression in the HUNT 2 study. International Journal of Methods in Psychiatric Research 18, 128137.
Brown, WA (2007). Treatment response in melancholia. Acta Psychiatrica Scandinavica 433, 125129.
Bruhl, AB, Kaffenberger, T, Herwig, U (2010). Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants. Neuropsychopharmacology 35, 521533.
Carney, MWP, Roth, M, Garside, RF (1965). The diagnosis of depressive syndromes and the prediction of E.C.T. response. British Journal of Psychiatry 111, 659674.
Chen, CH, Ridler, K, Suckling, J, Williams, S, Fu, CH, Merlo-Pich, E, Bullmore, E (2007). Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biological Psychiatry 62, 407414.
Deyi, BA, Kosinski, AS, Snapinn, SM (1998). Power considerations when a continuous outcome variable is dichotomized. Journal of Biopharmaceutical Statistics 8, 337352.
Dimidjian, S, Hollon, SD, Dobson, KS, Schmaling, KB, Kohlenberg, RJ, Addis, ME, Gallop, R, McGlinchey, JB, Markley, DK, Gollan, JK, Atkins, DC, Dunner, DL, Jacobson, NS (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology 74, 658670.
Fava, M, Rush, AJ, Alpert, JE, Balasubramani, GK, Wisniewski, SR, Carmin, CN, Biggs, MM, Zisook, S, Leuchter, A, Howland, R, Warden, D, Trivedi, MH (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry 165, 342351.
Fava, M, Uebelacker, LA, Alpert, JE, Nierenberg, AA, Pava, JA, Rosenbaum, JF (1997). Major depressive subtypes and treatment response. Biological Psychiatry 42, 568576.
Flett, GL, Vredenburg, K, Krames, L (1997). The continuity of depression in clinical and nonclinical samples. Psychological Bulletin 121, 395416.
Frank, E, Prien, RF, Jarrett, RB, Keller, MB, Kupfer, DJ, Lavori, PW, Rush, AJ, Weissman, MM (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry 48, 851855.
Hamilton, M (1967). Development of a rating scale for primary depressive illness. British Journal of Clinical Psychology 6, 278296.
Howland, RH, Wilson, MG, Kornstein, SG, Clayton, AH, Trivedi, MH, Wohlreich, MM, Fava, M (2008). Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression. Annals of Clinical Psychiatry 20, 209218.
Jacobson, NS, Dobson, KS, Truax, PA, Addis, ME, Koerner, K, Gollan, JK, Gortner, E, Prince, SE (1996). A component analysis of cognitive-behavioral treatment for depression. Journal of Consulting and Clinical Psychology 64, 295304.
Joyce, PR, Mulder, RT, McKenzie, JM, Luty, SE, Cloninger, CR (2004). Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline. Depression and Anxiety 19, 180186.
Korszun, A, Moskvina, V, Brewster, S, Craddock, N, Ferrero, F, Gill, M, Jones, IR, Jones, LA, Maier, W, Mors, O, Owen, MJ, Preisig, M, Reich, T, Rietschel, M, Farmer, A, McGuffin, P (2004). Familiality of symptom dimensions in depression. Archives of General Psychiatry 61, 468474.
Kraemer, HC, Kupfer, DJ (2006). Size of treatment effects and their importance to clinical research and practice. Biological Psychiatry 59, 990996.
Leuchter, AF, Cook, IA, Gilmer, WS, Marangell, LB, Burgoyne, KS, Howland, RH, Trivedi, MH, Zisook, S, Jain, R, Fava, M, Iosifescu, D, Greenwald, S (2009). Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Research 169, 132138.
Leykin, Y, Amsterdam, JD, DeRubeis, RJ, Gallop, R, Shelton, RC, Hollon, SD (2007). Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. Journal of Consulting and Clinical Psychology 75, 267276.
Mallinckrodt, CH, Zhang, L, Prucka, WR, Millen, BA (2010). Signal detection and placebo response in schizophrenia: parallels with depression. Psychopharmacology Bulletin 43, 5372.
McGrath, PJ, Khan, AY, Trivedi, MH, Stewart, JW, Morris, DW, Wisniewski, SR, Miyahara, S, Nierenberg, AA, Fava, M, Rush, JA (2008). Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. Journal of Clinical Psychiatry 69, 18471855.
McGrath, PJ, Stewart, JW, Janal, MN, Petkova, E, Quitkin, FM, Klein, DF (2000). A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. American Journal of Psychiatry 157, 344350.
Mead, GE, Morley, W, Campbell, P, Greig, CA, McMurdo, M, Lawlor, DA (2009). Exercise for depression. Cochrane Database of Systematic Reviews (4), CD004366.
Montgomery, SA, Åsberg, M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382389.
Nelson, JC (2010). Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials. Depression and Anxiety 27, 1218.
Parker, G (2007). Defining melancholia: the primacy of psychomotor disturbance. Acta Psychiatrica Scandinavica. Supplementum (433), 2130.
Parker, G, Fletcher, K, Hyett, M, Hadzi-Pavlovic, D, Barrett, M, Synnott, H (2009). Measuring melancholia: the utility of a prototypic symptom approach. Psychological Medicine 39, 989998.
Parker, G, Wilhelm, K, Mitchell, P, Roy, K, Hadzi-Pavlovic, D (1999). Subtyping depression: testing algorithms and identification of a tiered model. Journal of Nervous and Mental Disease 187, 610617.
Paykel, ES, Rowan, PR, Parker, RR, Bhat, AV (1982). Response to phenelzine and amitriptyline in subtypes of outpatient depression. Archives of General Psychiatry 39, 10411049.
Perlis, RH, Patrick, A, Smoller, JW, Wang, PS (2009). When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study. Neuropsychopharmacology 34, 22272236.
Perry, PJ (1996). Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. Journal of Affective Disorders 39, 16.
Prisciandaro, JJ, Roberts, JE (2005). A taxometric investigation of unipolar depression in the National Comorbidity Survey. Journal of Abnormal Psychology 114, 718728.
Prisciandaro, JJ, Roberts, JE (2009). A comparison of the predictive abilities of dimensional and categorical models of unipolar depression in the National Comorbidity Survey. Psychological Medicine 39, 10871096.
Raison, CL, Borisov, AS, Majer, M, Drake, DF, Pagnoni, G, Woolwine, BJ, Vogt, GJ, Massung, B, Miller, AH (2009). Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biological Psychiatry 65, 296303.
Rasmussen, NA, Schroder, P, Olsen, LR, Brodsgaard, M, Unden, M, Bech, P (2005). Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92). Nordic Journal of Psychiatry 59, 173178.
Rush, AJ, Gullion, CM, Basco, MR, Jarrett, RB, Trivedi, MH (1996). The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychological Medicine 26, 477486.
Rush, AJ, Trivedi, MH, Ibrahim, HM, Carmody, TJ, Arnow, B, Klein, DN, Markowitz, JC, Ninan, PT, Kornstein, S, Manber, R, Thase, ME, Kocsis, JH, Keller, MB (2003). The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry 54, 573583.
Rush, AJ, Trivedi, MH, Wisniewski, SR, Nierenberg, AA, Stewart, JW, Warden, D, Niederehe, G, Thase, ME, Lavori, PW, Lebowitz, BD, McGrath, PJ, Rosenbaum, JF, Sackeim, HA, Kupfer, DJ, Luther, J, Fava, M (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry 163, 19051917.
Russell, JM, Koran, LM, Rush, J, Hirschfeld, RM, Harrison, W, Friedman, ES, Davis, S, Keller, M (2001). Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depression and Anxiety 13, 1827.
Schatzberg, AF, Rush, AJ, Arnow, BA, Banks, PL, Blalock, JA, Borian, FE, Howland, R, Klein, DN, Kocsis, JH, Kornstein, SG, Manber, R, Markowitz, JC, Miller, I, Ninan, PT, Rothbaum, BO, Thase, ME, Trivedi, MH, Keller, MB (2005). Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Archives of General Psychiatry 62, 513520.
Siegle, GJ, Steinhauer, SR, Friedman, ES, Thompson, WS, Thase, ME (2011). Remission prognosis for cognitive therapy for recurrent depression using the pupil: utility and neural correlates. Biological Psychiatry 69, 726733.
Stewart, JW, McGrath, PJ, Fava, M, Wisniewski, SR, Zisook, S, Cook, I, Nierenberg, AA, Trivedi, MH, Balasubramani, GK, Warden, D, Lesser, I, John, RA (2010). Do atypical features affect outcome in depressed outpatients treated with citalopram? International Journal of Neuropsychopharmacology 13, 1530.
Streiner, DL (2002). Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Canadian Journal of Psychiatry 47, 262266.
Taylor, MJ, Freemantle, N, Geddes, JR, Bhagwagar, Z (2006). Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Archives of General Psychiatry 63, 12171223.
Thase, ME (2009). Atypical depression: useful concept, but it's time to revise the DSM-IV criteria. Neuropsychopharmacology 34, 26332641.
Thase, ME, Fava, M, DeBattista, C, Arora, S, Hughes, RJ (2006). Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. CNS Spectrums 11, 93–102.
Trivedi, MH, Rush, AJ, Wisniewski, SR, Nierenberg, AA, Warden, D, Ritz, L, Norquist, G, Howland, RH, Lebowitz, B, McGrath, PJ, Shores-Wilson, K, Biggs, MM, Balasubramani, GK, Fava, M (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry 163, 2840.
Uher, R, Dernovsek, MZ, Mors, O, Hauser, J, Souery, D, Zobel, A, Maier, W, Henigsberg, N, Kalember, P, Rietschel, M, Placentino, A, Mendlewicz, J, Aitchison, KJ, McGuffin, P, Farmer, A (2011). Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. Journal of Affective Disorders 132, 112120.
Uher, R, Farmer, A, Maier, W, Rietschel, M, Hauser, J, Marusic, A, Mors, O, Elkin, A, Williamson, RJ, Schmael, C, Henigsberg, N, Perez, J, Mendlewicz, J, Janzing, JG, Zobel, A, Skibinska, M, Kozel, D, Stamp, AS, Bajs, M, Placentino, A, Barreto, M, McGuffin, P, Aitchison, KJ (2008). Measuring depression: comparison and integration of three scales in the GENDEP study. Psychological Medicine 38, 289300.
Uher, R, Maier, W, Hauser, J, Marusic, A, Schmael, C, Mors, O, Henigsberg, N, Souery, D, Placentino, A, Rietschel, M, Zobel, A, Dmitrzak-Weglarz, M, Petrovic, A, Jorgensen, L, Kalember, P, Giovannini, C, Barreto, M, Elkin, A, Landau, S, Farmer, A, Aitchison, KJ, McGuffin, P (2009 a). Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. British Journal of Psychiatry 194, 252259.
Uher, R, Mors, O, Hauser, J, Rietschel, M, Maier, W, Kozel, D, Henigsberg, N, Souery, D, Placentino, A, Perroud, N, Dernovsek, MZ, Strohmaier, J, Larsen, ER, Zobel, A, Leszczynska-Rodziewicz, A, Kalember, P, Pedrini, L, Linotte, S, Gunasinghe, C, Aitchison, KJ, McGuffin, P, Farmer, A (2009 b). Body weight as a predictor of antidepressant efficacy in the GENDEP project. Journal of Affective Disorders 118, 147154.
Uher, R, Mors, O, Rietschel, M, Rajewska-Rager, A, Petrovic, A, Zobel, A, Henigsberg, N, Mendlewicz, J, Aitchison, KJ, Farmer, A, McGuffin, P (in press). Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression. Journal of Clinical Psychiatry.
Uher, R, Muthen, B, Souery, D, Mors, O, Jaracz, J, Placentino, A, Petrovic, A, Zobel, A, Henigsberg, N, Rietschel, M, Aitchison, KJ, Farmer, A, McGuffin, P (2010). Trajectories of change in depression severity during treatment with antidepressants. Psychological Medicine 40, 13671377.
Veen, G, van Vliet, IN, Derijk, RH, Giltay, EJ, van Pelt, J, Zitman, FG (2011). Basal cortisol levels in relation to dimensions and DSM-IV categories of depression and anxiety. Psychiatry Research 185, 121128.
Wardenaar, KJ, Vreeburg, SA, van Veen, T, Giltay, EJ, Veen, G, Penninx, BW, Zitman, FG (2011). Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis. Biological Psychiatry 69, 366373.
Wing, JK, Sartorius, N, Ustin, TB (1998). Diagnosis and Clinical Measurement in Psychiatry. A Reference Manual for SCAN. World Health Organization: Geneva.


Related content

Powered by UNSILO
Type Description Title
Supplementary materials

Uher Supplementary Material
Uher Supplementary Material

 Word (154 KB)
154 KB

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

  • R. Uher (a1), R. H. Perlis (a2), N. Henigsberg (a3), A. Zobel (a4), M. Rietschel (a5), O. Mors (a6), J. Hauser (a7), M. Z. Dernovsek (a8), D. Souery (a9), M. Bajs (a3), W. Maier (a4), K. J. Aitchison (a1), A. Farmer (a1) and P. McGuffin (a1)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.